Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Utilizing marine sources to extract DHA to treat Alzheimer’s

The anti-neurodegenerative effects of docosahexaenoic acid (DHA) and DHA-rich phospholipids (DH-PL) derived from fisheries and aquaculture byproducts.

15 Nov 2022

The brain's claustrum behaves more like a high-speed internet router, research finds

Tucked underneath the brain's outer, wrinkly cortex is a deeply mysterious area, known as the claustrum. This region has long been known to exchange signals with much of the cortex, which is responsible for higher reasoning and complex thought.

14 Nov 2022

Understanding why people feel lonely in later life

Not everyone's holiday plans resemble a Hallmark card. If the "most wonderful time of the year" isn't your reality, you're not alone. You might have an idea of a festive picture-perfect holiday season, but what actually transpires doesn't always measure up.

14 Nov 2022

Study highlights the complexity of health-care costs for ADRD patients who develop delirium

Alzheimer's Dementia and Related Disorders (ADRD) affects upwards of 5 million people in the United States, with no known treatments to stop or prevent its progression.

14 Nov 2022

New online tool launched to increase awareness and participation in Alzheimer’s clinical trials

Also at AAIC 2021, the National Institute on Aging (NIA), part of the U.S. National Institutes of Health, launched a new online tool, Outreach Pro, to help researchers and clinicians increase awareness and participation in clinical trials on Alzheimer's disease and other dementias, especially among traditionally underrepresented communities.

14 Nov 2022

Older adults suffer from persistent cognitive impairment after recovery from SARS-CoV-2 infection

In addition to the respiratory and gastrointestinal symptoms that accompany COVID-19, many people with the virus experience short- and/or long-term neuropsychiatric symptoms, including loss of smell and taste, and cognitive and attention deficits, known as "brain fog."

14 Nov 2022

How air pollution affects the central nervous system over time

An article published in the journal Toxics describes how air pollutants adversely impact the human nervous system.

13 Nov 2022

People with Alzheimer's disease can be identified before any symptoms appear

A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms.

11 Nov 2022

Study shows biological link between muscle weakness and acceleration in biological age

Everyone ages at a different pace. That's why two 50-year-olds, despite living the same number of years, may have different biological ages – meaning that a host of intrinsic and extrinsic factors have caused them to age at varying paces with different levels of risk for disease and early death.

10 Nov 2022

New approach can help design shorter, more powerful trials to assess Parkinson’s drugs

Testing whether a new drug impacts the progression of Parkinson's disease takes years, in part because the disease often advances so slowly.

10 Nov 2022

The roles of innate and adaptive immunity in Alzheimer’s disease development and progression

Researchers reviewed research advancements showing the significant role both innate and adaptive immune systems play in the pathological course of Alzheimer’s disease.

10 Nov 2022

Characteristics of patients' drawing process can determine the type of dementia, study finds

The two most common neurodegenerative dementias are Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). There is often an overlap of symptoms across these two diseases, which can make diagnoses difficult.

9 Nov 2022

New biomarker could aid in early diagnosis of Alzheimer’s disease

A definitive diagnosis of Alzheimer's disease (AD) was once only possible after someone had died, but recent biomarker studies have led to the development of imaging and spinal fluid tests for those still living.

9 Nov 2022

Long-term effects of SARS-CoV-2 on the brain

More profoundly than previously believed, the virus that causes COVID-19, SARS-CoV-2, can impact the brain for months after infection.

9 Nov 2022

Researchers find an innovative approach to improve waste clearance from the brain

Alzheimer's, Parkinson's and many other neurodegenerative diseases are marked by damaging clusters of proteins in the brain. Scientists have expended enormous effort searching for ways to treat such conditions by clearing these toxic clusters but have had limited success.

9 Nov 2022

Collaboration aims to develop new medicines for neurodegenerative diseases

The ALBORADA Drug Discovery Institute (ADDI) today (Tuesday 8 November) announced that it will collaborate with pharmaceutical company YD Global Life Science (YDGLS) to develop inhibitors of the unfolded protein response for the treatment of the diseases that cause dementia.

9 Nov 2022

Researchers use lasso-grafting for designing receptor agonists with enhanced pharmacokinetics

Cell growth and repair are stimulated by biomolecules known as cytokines and growth factors. Unfortunately, delivering adequate concentrations of these molecules to the brain for treating neurological conditions like Alzheimer's disease is challenging as they are either cleared out of the blood very quickly or do not penetrate neural tissue effectively.

8 Nov 2022

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Utilizing marine sources to extract DHA to treat Alzheimer’s

The brain's claustrum behaves more like a high-speed internet router, research finds

Understanding why people feel lonely in later life

Study highlights the complexity of health-care costs for ADRD patients who develop delirium

New online tool launched to increase awareness and participation in Alzheimer’s clinical trials

Older adults suffer from persistent cognitive impairment after recovery from SARS-CoV-2 infection

How air pollution affects the central nervous system over time

People with Alzheimer's disease can be identified before any symptoms appear

Study shows biological link between muscle weakness and acceleration in biological age

New approach can help design shorter, more powerful trials to assess Parkinson’s drugs

The roles of innate and adaptive immunity in Alzheimer’s disease development and progression

Characteristics of patients' drawing process can determine the type of dementia, study finds

New biomarker could aid in early diagnosis of Alzheimer’s disease

Long-term effects of SARS-CoV-2 on the brain

Researchers find an innovative approach to improve waste clearance from the brain

Collaboration aims to develop new medicines for neurodegenerative diseases

Researchers use lasso-grafting for designing receptor agonists with enhanced pharmacokinetics

UQ researchers discover a link between obstructive sleep apnea and dementia

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease

Study reveals the extent of aggression towards caregivers in Parkinson's disease

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in